Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Ubrogepant NCT05125302 · Ubro Peds — Study to Assess Adverse Events and Disease Activity of Oral Ubrogepa… | Migraine | À vérifier | Phase 3 | RECRUITING | Migraine is a common neurological disorder typically characterized by atta… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Elismetrep NCT07674654 · A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine | Migraine | À vérifier | Phase 3 | RECRUITING | This is a long-term safety study to evaluate the safety and tolerability o… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| Eptinezumab NCT07191145 · Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (EL… | Migraine | Traitement symptomatique | Phase 3 | NOT_YET_RECRUITING | Most individuals with mild traumatic brain injury (mTBI) experience post-t… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| greater occipital nerve block NCT07763678 · Efficacy of Ultrasound-Guided Combined Greater Occipital Nerve Block and Greater… | Migraine | Ralentissement de la progression · Traitement symptomatique | Phase 4 | NOT_YET_RECRUITING | Migraine is one of the most prevalent neurological disorders worldwide and… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| Neurostimulator NCT07719608 · RECLAIM-II — A Pivotal Clinical Study to Evaluate the MySalvia System for the Tr… | Migraine | À vérifier | Non applicable | RECRUITING | The purpose of this pivotal clinical study is to evaluate the safety and e… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| NIMH Rhythms and Blues Study: A Prospective Natural History Study of… NCT05669703 · NCT05669703 | Migraine | Thérapie génique | À vérifier | RECRUITING | Background: Mood disorders, such as bipolar disorder, can have serious eff… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| The Effect of Two Different Massages on Migraine NCT05452330 · NCT05452330 | Migraine | Ralentissement de la progression · Traitement symptomatique | Non applicable | COMPLETED | The study aims to compare the effects of connective tissue massage on pain… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:02 | Détail |
| VNS device NCT02791893 · Vagus Nerve Stimulation: Treatment for Gulf Veterans With Gulf War Illness | Sclérose en plaques | Traitement symptomatique | Non applicable | COMPLETED | The researchers propose studying Gulf veterans with Gulf War Illness (GWI)… À vérifier | ClinicalTrials.gov 2026-08-13 14:16:47 | Détail |
| Sham Transcranial direct current stimulation Étude non communiquée | Migraine · Sclérose en plaques | À vérifier | Non applicable | Actif | This research is being done to determine whether transcranial direct curre… À vérifier | ClinicalTrials.gov 2026-08-12 | Détail |
| Greater Auricular Nerve Block Étude non communiquée | Migraine | Ralentissement de la progression · Traitement symptomatique | Phase 4 | Prévu | Migraine is one of the most prevalent neurological disorders worldwide and… À vérifier | ClinicalTrials.gov 2026-08-10 | Détail |
| Saline 0.9% Étude non communiquée | Migraine | Traitement symptomatique | Phase 2 | Prévu | The goal of this double-blinded, randomized placebo controlled clinical tr… À vérifier | ClinicalTrials.gov 2026-08-10 | Détail |
| H.P. Acthar Gel NCT01813591 · A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Mig… | Migraine | Immunomodulation · Traitement symptomatique | Phase 2 | COMPLETED | This small study is to investigate the efficacy of Acthar in the treatment… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:17 | Détail |
| Lidocaine Hydrochloride NCT06462781 · LIGHT 1 — Localized Injection of Lidocaine and Glucocorticoid for Headache Treat… | Migraine | Traitement symptomatique | Phase 1 | COMPLETED | This randomized clinical trial will aim to compare the effectiveness of dr… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:17 | Détail |
| antibodies against calcitonin-gene related peptide or its receptor NCT04019496 · Neurophysiology of Prophylactic Treatment in Migraine | Migraine | Traitement symptomatique | À vérifier | COMPLETED | This study aims to improve the pathophysiological understanding of migrain… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| Care as usual NCT03395457 · Tertiary Care With or Without Manual Therapy for Chronic Migraine | Migraine | À vérifier | NA | COMPLETED | The aim of this study is to determine if adding manual therapy to care as… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| Click Digital Therapeutic NCT06004388 · Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiv… | Migraine | À vérifier | Phase 3 | COMPLETED | Randomized study of two digital therapeutics for the prevention of episodi… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| Evaluation of a Mind-body Based Application for the Treatment of Chro… NCT05090683 · NCT05090683 | Migraine | Traitement symptomatique | NA | COMPLETED | We are investigating the effects of a mind-body based mobile application o… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| Lasmiditan NCT05903040 · Ditan Acute tReatments: Effectiveness and Tolerability (DART) | Migraine | À vérifier | À vérifier | COMPLETED | The purpose of this study is to evaluate the efficacy and safety of a rang… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| MEDI0618 NCT06602479 · AURORA — A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to… | Migraine | À vérifier | Phase 2 | RECRUITING | The purpose of this Phase 2 study is to evaluate the safety and efficacy o… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
| PRESTO — IndoProCaf Effervescent Tablets Effectiveness in Acute Treat… NCT02115269 · PRESTO — IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Mig… | Migraine | À vérifier | À vérifier | COMPLETED | Headaches are a common medical problem that physicians frequently encounte… À vérifier | ClinicalTrials.gov 2026-08-08 00:54:16 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migrai… Sumatriptan 50 mg · PMID 38886287 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Around 91% of migraine patients use over-the-counter medicines to treat attacks, often without further treatment or med… | Pain and therapy 2026-08-16 21:22:02 | Source |
| Comparing the efficacy of eletriptan for migraine in women during men… Eletriptan 20 mg · PMID 24256184 | Migraine | Ralentissement de la progression | Publication | PubMed | Voir la publication source To assess the efficacy and tolerability of eletriptan in treating migraine attacks occurring within the defined menstru… | Headache 2026-08-16 21:22:01 | Source |
| Economic analysis of triptan therapy for acute migraine: a Medicaid p… Eletriptan 20 mg · PMID 17655509 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To compare triptan therapies for migraine in terms of the cost to treat 100 migraine attacks and the cost per successfu… | Pharmacotherapy 2026-08-16 21:22:01 | Source |
| Perimenstrual eletriptan prevents menstrual migraine: an open-label s… Eletriptan 20 mg · PMID 20236337 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source To prospectively evaluate the efficacy of perimenstrual prophylaxis with eletriptan to reduce headaches in women identi… | Headache 2026-08-16 21:22:01 | Source |
| Massively parallel single-cell chromatin landscapes of human immune c… CBD 200 mg OD · PMID 31375813 | Migraine | Immunomodulation | Publication | PubMed | Voir la publication source Understanding complex tissues requires single-cell deconstruction of gene regulation with precision and scale. Here, we… | Nature biotechnology 2026-08-16 19:26:32 | Source |
| Motor function of the opossum sphincter of Oddi. CBD 200 mg OD · PMID 6822661 | Migraine | À vérifier | Publication | PubMed | Voir la publication source We studied the opossum sphincter of Oddi (SO) because in this species the SO is approximately 3 cm in length and its ex… | The Journal of clinical investigation 2026-08-16 19:26:32 | Source |
| Cannabidiol Attenuates Heroin Seeking in Male Rats Associated With No… CBD 100 mg OD · PMID 40992584 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Opioid use disorder is a chronic relapsing condition characterized by cycles of compulsive drug use, abstinence, and re… | Biological psychiatry 2026-08-16 19:26:31 | Source |
| Maternal ingestion of cannabidiol (CBD) in mice leads to sex-dependen… CBD 100 mg OD · PMID 39481653 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source The consequences of perinatal cannabidiol (CBD) exposure are severely understudied, but are important, given its widesp… | Pharmacology, biochemistry, and behavior 2026-08-16 19:26:31 | Source |
| 1-Deoxynojirimycin attenuates diabetic cardiomyopathy via PI3K/AKT-me… Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Contro… | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Publication | PubMed | Voir la publication source 1-Deoxynojirimycin (DNJ), a naturally occurring alkaloid derived from mulberry leaves (Morus alba L.), is a powerful α-… | Journal of ethnopharmacology 2026-08-16 19:26:30 | Source |
| Zhenwu Decoction ameliorates experimental benign prostatic hyperplasi… Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Contro… | Migraine | Remyélinisation indirecte / réparation · Neuroprotection · Traitement symptomat… | Publication | PubMed | Voir la publication source Zhenwu Decoction (ZWD), first recorded in the Shang Han Lun, is a classical formula used to warm Yang and promote water… | Journal of ethnopharmacology 2026-08-16 19:26:30 | Source |
| A Randomized Controlled Trial of Instillation Protocols Prior to Intr… onabotulinumtoxinA prophylaxis with Lidocaine · PMID 40025238 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Achieving adequate pain relief is crucial for intradetrusor onabotulinumtoxinA treatments for idiopathic overactive bla… | International urogynecology journal 2026-08-16 19:26:28 | Source |
| A phase 1, multicenter, open-label study to evaluate the pharmacokine… Rimegepant 75 mg ODT · PMID 41133671 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To evaluate pharmacokinetics (PK), safety, and tolerability of a weight-adjusted dose of rimegepant orally disintegrati… | Headache 2026-08-16 19:26:27 | Source |
| A randomized open-label study to evaluate the effectiveness and safet… Rimegepant 75 mg ODT · PMID 40734466 | Migraine | À vérifier | Publication | PubMed | Voir la publication source AimTo evaluate rimegepant, a calcitonin gene-related peptide receptor antagonist, for short-term prevention of fasting-… | Cephalalgia : an international journal of headache 2026-08-16 19:26:27 | Source |
| Rimegepant for acute treatment of migraine in triptan-unsuitable adul… Rimegepant 75 mg ODT · PMID 41255093 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source BackgroundA subset of individuals with migraine are unsuitable for triptans due to intolerance, lack of efficacy, or co… | Cephalalgia : an international journal of headache 2026-08-16 19:26:27 | Source |
| Decoding the serotonin-alcohol crosstalk: the role of central seroton… Serotonergic Psychedelic · PMID 42329577 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Serotonin (5-hydroxytryptamine; 5-HT) is a key neuromodulator involved in the regulation of mood, appetite, aggression,… | Pharmacological reports : PR 2026-08-16 19:26:26 | Source |
| Proliferative Effects of the Psychedelic N,N-Dimethyltryptamine (DMT)… Serotonergic Psychedelic · PMID 42427129 | Migraine | Thérapie cellulaire | Publication | PubMed | Voir la publication source The serotonergic psychedelic N,N-dimethyltryptamine (DMT) produces rapid antidepressant effects in preclinical and earl… | ACS chemical neuroscience 2026-08-16 19:26:26 | Source |
| Botulinum toxin effects on biochemical biomarkers related to inflamma… Tear Biomarkers for Migraine · PMID 40035830 | Migraine | Neuroprotection · Immunomodulation · Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Botulinum toxin type A (BoNT) has emerged as a potential alternative to conventional therapies to many debilitating chr… | Journal of neural transmission (Vienna, Austria : 1996) 2026-08-16 19:26:25 | Source |
| Feasibility and Tolerability of Psilocybin for Phantom Limb Pain. Serotonergic Psychedelic · PMID 42567236 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Phantom limb pain (PLP) is a refractory condition defined by pain experienced in a missing limb. Psilocybin, a classica… | The journal of pain 2026-08-16 19:26:25 | Source |
| The ocular surface tear film as a biomarker for systemic health. Tear Biomarkers for Migraine · PMID 40345388 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The tear film is a complex structure with rich interactions with the human body. A growing body of evidence suggests th… | The ocular surface 2026-08-16 19:26:25 | Source |
| [Clinical practice guideline for migraine with traditional Chinese me… Yangxue Qingnao Granules (Pills) · PMID 33350221 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source The present clinical practice guideline was written by experts organized by the special group of key projects in the 13… | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi =… 2026-08-16 19:26:24 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |